Ibnsina Pharma net revenues rise 51.1% y-o-y to EGP 2.9bn in Q1 2018
Ibnsina Pharma achieved net revenues of EGP 2.9bn, up 51.1% year-over-year in…
Ibnsina Pharma targets 26% market share as it plans expansion
Company working in full swing to develop its distribution network
Ibnsina Pharma signs contracts with Novo Nordisk to distribute products in Egypt
Companies signed two contracts authorising Ibnsina Pharma to distribute 20+ stock-keeping units…
Ibnsina Pharma starts trading on EGX amid investor interest
Company accounted for 24% of Tuesday’s turnover, stock up 3.54%
Ibnsina Pharma set final IPO price at EGP 5.8 per share
The IPO has been oversubscribed 17.1 times through more than 500 institutions…
Ibnsina Pharma starts IPO of 25% of capital
Beltone Financial will take over the initial public offerings of the company’s…